Skip to main
HNGE

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 59%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health Inc. demonstrated strong financial performance with a nearly 44% year-over-year growth in calculated billings, reaching $671 million, alongside a 25% increase in client count to over 2,800, reflecting its effective market penetration. The company's revenue of $170.7 million also exceeded expectations, growing 46% year-over-year, and its guidance for future revenues indicates a positive outlook with projections of $732 million to $742 million for the upcoming year, a 25% increase at the midpoint. Furthermore, Hinge Health's ongoing utilization growth within its existing client base suggests a solid foundation for market share expansion in the coming years.

Bears say

The analysis reveals a negative outlook for Hinge Health's stock, primarily due to the anticipated impact of a macro-driven weak spending environment in the second half of 2025, which could lead to slower growth in FY26. Despite guidance indicating higher non-GAAP operating income and strong gross margins that exceed consensus estimates, concerns regarding the dependency on employee utilization for billing growth highlight the risk associated with the company's business model. Additionally, competitive challenges may arise from potential clients delaying decisions due to budgetary constraints, further complicating Hinge Health's growth prospects in the immediate future.

HNGE has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 59% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 17 analysts, HNGE has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $58.65, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $58.65, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.